Overall, germline causative variants in SMAD4 and BMPR1A account for about 45–55% of cases of individuals with one or more clinical criteria of JPS, suggesting that genetic variants in other genes may contribute to JPS etiology. This evidence concerns the gene SMAD4 and juvenile polyposis syndrome.